Clinical Trial Update: Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating deferiprone together with incretin-based therapy for Wolfram syndrome type 2, with attention to related diabetes, optic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroduodenal Ulcer
• Iron Metabolism Disorders
• Optic Atrophy
• Platelet Dysfunction
• Sensorineural Hearing Loss
• Wolfram Syndrome Type 2

Drugs mentioned

• Deferiprone (deferiprone)
• Incretin-based therapy (unspecified)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Diabetes Mellitus, Iron Metabolism Disorders | Phase 2, Phase 3 | Status: UNKNOWN